Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
about
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel DiseaseMesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune RegulationMesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?T Cells and Cancer: How Metabolism Shapes ImmunityThe Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of InfluenzaTargeting the indoleamine 2,3-dioxygenase pathway in cancerIndoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's DiseaseThe potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapyTryptophan Catabolism in Chronic Viral Infections: Handling Uninvited GuestsDisturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric SymptomsAntioxidants, inflammation and cardiovascular diseaseWays to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesTrial watch: IDO inhibitors in cancer therapyDoes EBV alter the pathogenesis of malaria?Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNAIndoleamine 2,3 dioxygenase in intestinal diseaseImmunoregulation by mesenchymal stem cells: biological aspects and clinical applicationsNew Insights into IDO Biology in Bacterial and Viral Infections.Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationThe Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for ImmunotherapyEvasion of host immune defenses by human papillomavirusImmune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacyMolecular basis for catalysis and substrate-mediated cellular stabilization of human tryptophan 2,3-dioxygenaseT cell exclusion, immune privilege, and the tumor microenvironmentHyperoxygenation attenuated a murine model of atopic dermatitis through raising skin level of ROSIDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer CellsHigh-throughput detection of miRNAs and gene-specific mRNA at the single-cell level by flow cytometryImmunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapyB-Cell Depletion Promotes Aortic Infiltration of Immunosuppressive Cells and Is Protective of Experimental Aortic Aneurysm.Plasma Tryptophan and the Kynurenine-Tryptophan Ratio are Associated with the Acquisition of Statural Growth Deficits and Oral Vaccine Underperformance in Populations with Environmental Enteropathy.Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy.Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniaeTryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers.The role of placental tryptophan catabolismIndoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.Tryptophan catabolism and immune activation in primary and chronic HIV infectionFunction and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis.Human adipose-derived mesenchymal stem cells alleviate obliterative bronchiolitis in a murine model via IDO.Activation of the STING adaptor attenuates experimental autoimmune encephalitis.Human Neural Stem Cell Therapy for Chronic Ischemic Stroke: Charting Progress from Laboratory to Patients.
P2860
Q26741117-7F22946A-14F7-4D64-9654-AEA35BFD58A0Q26741252-14AC3BBA-65FD-4B09-8013-D35087E362C2Q26746104-62E19F42-2ACC-4E9B-9FD8-B8F8412DCEB0Q26766427-68BF0D8E-9ED1-4D84-B527-94C539261BDDQ26772701-53938122-FE80-40B3-81BB-CE1555C82A7EQ26775471-D2320945-FEAB-479B-95FB-245085BE2A04Q26781849-77DB4A2C-AF87-4FBA-9127-B6F5A6B44F4AQ26783291-B29C6C61-2C4F-4A95-B8A7-765433BC906AQ26797214-55E02B17-C991-408E-A84D-6B1A6751CC14Q26800052-B4F0CF33-1363-44E1-9E8E-E4A97E396F41Q26823009-4EA5A804-100D-4C71-B6EF-9BA7B52E44CCQ26991991-90B0C358-A8C4-4385-9B6E-2C357CF2B472Q27006866-EF85272D-522E-4FF1-861B-C2CABD65A18FQ27022038-45C1A825-06D6-4408-9EC5-0D4CA2C9C35AQ27022855-853A4A3B-5A1A-43DE-8806-635F31D0F320Q27025063-C4FFEB03-36EA-434F-B43B-9ED9C4BA9E44Q27026892-F63438D9-2005-4C92-95E0-89BC5B5AEF88Q27692028-DF86662A-ACC4-4537-8476-7ADA41358C9FQ28068378-1BE5DC0A-DC04-4B46-8353-6C44A8D53187Q28073631-D260705C-21D9-4D37-8C26-5DA3B73375DEQ28076194-B8765F16-C8F8-4FC4-89DB-869C3AA64E44Q28082914-83E29B0C-711E-4ADC-A575-14C42BCACA5EQ28115713-FD62DC01-422F-4A4C-BD61-22EEA4565E3CQ28259872-4472A786-420E-4DE5-BCD4-0205A13050EFQ28543509-C7BDBEB8-EC36-44D2-ADC7-C590053D3112Q28551043-A9B268C9-1137-48BE-B71B-DD6BF3BA664BQ28650315-147A5AEC-A908-4830-945B-8388FD82E10BQ29994669-3A996AEF-8A67-456D-8FA6-38D233CB5650Q30275599-C73A3535-B3F0-4919-AAE0-4F57D7494F60Q30276161-2530EC62-9514-4D04-8076-8A86E66B9CBCQ30578330-A770E3BE-CF5D-44F9-AA4D-1574AE58CE4BQ33570163-7714649B-DBF9-4A2E-A348-A08A3E78DE19Q33585122-8442AFBB-6BD8-4242-855D-008153774A85Q33657987-208FABF0-BFC3-4B60-A490-3BEE74804CC3Q33688517-18A7BCA9-7880-4EBC-AF65-1F5023767E5BQ33697163-EB338262-AD3A-4F77-80E5-7DBFCA6DAD37Q33710719-4365EAE4-F237-4ED6-94A4-4EFF33F2A9C2Q33805077-7070E2B7-81A6-43EB-A338-41F24CBEEC17Q33861332-AA988A00-D1E2-45E8-8137-8F3AF14DA7D1Q33904790-56A04CC5-0C00-4C37-A680-306E72ABAA77
P2860
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
@ast
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
@en
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
@nl
type
label
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
@ast
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
@en
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
@nl
prefLabel
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
@ast
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
@en
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
@nl
P2860
P356
P1433
P1476
Indoleamine 2,3 dioxygenase and metabolic control of immune responses.
@en
P2093
Andrew L Mellor
David H Munn
P2860
P304
P356
10.1016/J.IT.2012.10.001
P577
2012-10-25T00:00:00Z